Quick Asked: Tocagen Contact Us?

Are you searching for Tocagen Contact Us? By using our below available official links ( which are always up to date), you can find contact information without any difficulty. It may list Phone number, Mobile phone, Email Address & Customer service information.
Last update: 16 Apr, 2024 212 Views

What other companies does tocagen own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tocagen investors own include Selecta Biosciences (SELB), Inovio Pharmaceuticals (INO), VBI Vaccines (VBIV), SCYNEXIS (SCYX), Catalyst Pharmaceuticals (CPRX), T2 Biosystems (TTOO), Amarin (AMRN), Novavax (NVAX), OPKO Health (OPK) and Amicus Therapeutics (FOLD).

How much does tocagen make a year? Tocagen has a market capitalization of $674.28 million and generates $40,000.00 in revenue each year. The company earns $-63,520,000.00 in net income (profit) each year or ($2.69) on an earnings per share basis. How many employees does Tocagen have?

What is the mailing address for targettocagen? Tocagen's mailing address is 4242 CAMPUS POINT COURT SUITE 500, SAN DIEGO CA, 92121. The company can be reached via phone at 858-412-8400 or via email at [email protected].

How many shares did tocagen issue in its ipo? The company issued 7,300,000 shares at $10.00-$12.00 per share. Leerink Partners, Evercore ISI and Stifel served as the underwriters for the IPO. What is Tocagen's stock symbol?

Listing Results Tocagen Contact Us? Question Answers

Tocagen and Forte Biosciences Announce Merger More News

(858) 412-8400 Once filed, the Registration Statement will be available free of charge on Tocagen's website at https://tocagen.com, by contacting Tocagen's Investor Contact, Mark Foletta, by phone at (858) 412-8400, or by electronic mail at This email address is being protected from spambots. You need JavaScript enabled to view it..

BRIEFTocagen Says On April 28 Received Notice From Nasdaq

* TOCAGEN SAYS ON APRIL 28 RECEIVED NOTICE FROM NASDAQ - SEC FILING They may be set by us or by third party providers whose services we have added to our pages. you may contact our legal

Tocagen's gene therapy offers early hope for aggressive

Tocagen’s new gene therapy offers a flicker of hope for aggressive brain cancer. By Adam Feuerstein. Oct. 27, 2017. Reprints. A scan showing brain cancer. Michelle Monje/Stanford University/NIH

Xconomy: Tocagen Stock Tanks After Gene Therapy Drug for

Tocagen’s experimental gene therapy for brain cancer therapy has failed a late-stage test, sinking the biotech’s stock price below $1. San Diego’s Tocagen (NASDAQ: TOCA ), has been testing

Tocagen and Forte Biosciences Announce Merger

Once filed, the Registration Statement will be available free of charge on Tocagen's website at https://tocagen.com, by contacting Tocagen's Investor Contact, Mark Foletta, by phone at (858) 412

Did the information help you? If so, please share!
If you think the information on this page has been helpful to you, would you be willing to share it? Your sharing is the driving force for our continuous work.
  1. Home ›
  2. T ›
  3. Tocagen Contact Us?